Compare CNXN & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXN | TNDM |
|---|---|---|
| Founded | 1982 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1998 | 2013 |
| Metric | CNXN | TNDM |
|---|---|---|
| Price | $59.28 | $21.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $22.44 |
| AVG Volume (30 Days) | 76.0K | ★ 2.3M |
| Earning Date | 02-04-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $2,878,704,000.00 | $1,007,001,000.00 |
| Revenue This Year | $5.85 | $8.59 |
| Revenue Next Year | $4.52 | $10.19 |
| P/E Ratio | $18.61 | ★ N/A |
| Revenue Growth | 3.19 | ★ 17.87 |
| 52 Week Low | $54.97 | $9.98 |
| 52 Week High | $75.08 | $38.28 |
| Indicator | CNXN | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 65.30 |
| Support Level | $57.94 | $20.27 |
| Resistance Level | $61.65 | $22.10 |
| Average True Range (ATR) | 1.29 | 1.12 |
| MACD | 0.32 | -0.09 |
| Stochastic Oscillator | 34.90 | 85.52 |
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.